Resolute Innovation, Inc.
Resolute Innovation, Inc. is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Resolute Innovation, Inc..
Resolute Innovation, Inc. is a company.
Key people at Resolute Innovation, Inc..
ResoluteAI (also referenced as Resolute Innovation, Inc.) is a software platform that provides AI-powered tools for scientific research, innovation management, and knowledge discovery. It enables users to generate, analyze, and manage innovation processes, including patent portfolio organization, technology trend analysis, interactive analytics, downloadable visualizations, technology landscaping, and post-market surveillance.[1][2][3] Primarily serving scientific organizations in life sciences (pharma, biotech, MedTech), engineering, and chemicals, it addresses challenges in research & development, competitive intelligence, IP management, clinical operations, and business development by integrating taxonomies, ontologies, knowledge graphs, and large language models (LLMs) for efficient information retrieval.[1][2] Founded in 2015 in New York, the company raised $6.73M before being acquired by Research Solutions in July 2023, at which point it had ~$1.3M in annual recurring revenue.[1][2]
ResoluteAI was founded in 2015 in New York, New York, as a science research platform focused on advanced search and discovery tools.[1][2] Specific founders are not detailed in available sources, but the company emerged to tackle inefficiencies in scientific data analysis and innovation workflows, building expertise in AI, natural language processing (NLP), and integrated datasets for R&D-intensive sectors.[2] Early traction included developing tools for workflows like IP management and post-market surveillance; by April 2021, it launched features simplifying pharmacovigilance analysis.[1] A pivotal moment came in July 2023 when Research Solutions acquired it to enhance AI-driven innovation solutions, integrating ResoluteAI's technology into broader enterprise search and knowledge management capabilities.[2]
Competitors like Relecura (AI for patents and tech scouting), PatSnap, and Dolcera offer similar IP and market intel tools, but ResoluteAI stands out in pharmacovigilance and multi-industry knowledge graphs.[1]
ResoluteAI rides the wave of AI-driven innovation intelligence, where LLMs and NLP automate complex scientific data processing amid exploding patent volumes and regulatory demands in life sciences.[1][2] Timing aligns with post-2020 AI adoption surges, enabling faster R&D cycles for pharma/biotech amid pharmacovigilance market growth (projected to $23.31B by CAGR 13%).[1] Market forces like rising drug safety scrutiny and cross-industry tech scouting favor its tools, while the 2023 acquisition by Research Solutions amplifies its reach into cloud-based workflows for R&D organizations.[2] It influences the ecosystem by accelerating breakthroughs, reducing research time, and democratizing advanced analytics beyond big pharma to MedTech and engineering firms.[2]
Post-acquisition, ResoluteAI's tech will expand within Research Solutions' platform, targeting enterprise search across innovation stages and new sectors via LLM enhancements.[2] Trends like multimodal AI and real-time regulatory data will shape its path, potentially boosting ARR through integrated solutions for post-market and commercial use cases.[1][2] Its influence may evolve from standalone platform to core engine in AI-powered R&D ecosystems, powering confident decisions in high-stakes innovation—transforming how organizations from strategy to commercialization uncover hidden insights.[2]
Key people at Resolute Innovation, Inc..
